Concentra Reports Strong Q1 Results, Raises Full-Year 2026 Guidance, and Declares Dividend
Summary
Concentra reported strong Q1 2026 financial results with significant revenue and EPS growth, and raised its full-year 2026 guidance for key financial metrics, alongside declaring a quarterly cash dividend and continuing share repurchases.
Key Events
-
Strong Q1 Financial Performance
Concentra reported Q1 2026 revenue of $569.6 million, a 13.7% increase year-over-year, with net income rising 28.7% to $52.3 million and Adjusted EBITDA increasing 17.6% to $120.7 million. Earnings per share grew to $0.39 from $0.30 in the prior year.
-
Raised Full-Year 2026 Guidance
The company raised its full-year 2026 guidance, now expecting revenue in the range of $2.275 billion to $2.375 billion, Adjusted EBITDA between $460 million and $480 million, and Free Cash Flow from $215 million to $235 million. The net leverage ratio target remains below 3.0x.
-
Quarterly Cash Dividend Declared
The Board of Directors declared a cash dividend of $0.0625 per share, payable on or about June 9, 2026, to stockholders of record as of May 19, 2026.
-
Continued Share Repurchases
In the first quarter of 2026, Concentra repurchased approximately 0.7 million shares of common stock totaling $15.0 million, demonstrating ongoing commitment to returning value to shareholders.
Analysis
Concentra Group Holdings Parent, Inc. delivered robust first-quarter financial results, exceeding expectations with double-digit growth in revenue, net income, and Adjusted EBITDA. The company's decision to raise its full-year 2026 guidance for revenue, Adjusted EBITDA, and Free Cash Flow signals strong operational momentum and management confidence. This positive update, coupled with continued share repurchases and a declared cash dividend, reinforces a favorable outlook for investors, especially as the stock is currently trading near its 52-week high.
At the time of this filing, CON was trading at $24.70 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $3B. The 52-week trading range was $18.55 to $24.69. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.